241 related articles for article (PubMed ID: 32334898)
21. Risk-Stratified Venous Thromboembolism Prophylaxis after Total Joint Arthroplasty: Low Molecular Weight Heparins and Sequential Aspirin vs Aggressive Chemoprophylaxis.
Peng HM; Chen X; Wang YO; Bian YY; Feng B; Wang W; Weng XS; Qian WW
Orthop Surg; 2021 Feb; 13(1):260-266. PubMed ID: 33448672
[TBL] [Abstract][Full Text] [Related]
22. A risk-stratified approach to venous thromboembolism prophylaxis with aspirin or warfarin following total hip and knee arthroplasty: A cohort study.
Johnson SA; Jones AE; Young E; Jennings C; Simon K; Fleming RP; Witt DM
Thromb Res; 2021 Oct; 206():120-127. PubMed ID: 34455129
[TBL] [Abstract][Full Text] [Related]
23. Clinical efficacy of risk-stratified prophylaxis with low-dose aspirin for the management of symptomatic venous thromboembolism after total hip arthroplasty.
Mihara M; Tamaki Y; Nakura N; Takayanagi S; Saito A; Ochiai S; Hirakawa K
J Orthop Sci; 2020 Jan; 25(1):156-160. PubMed ID: 30902536
[TBL] [Abstract][Full Text] [Related]
24. Low-Dose Aspirin for Venous Thromboembolism Prophylaxis is Associated With Lower Rates of Periprosthetic Joint Infection After Total Joint Arthroplasty.
Najafi F; Kendal JK; Peterson NV; Ciesielka KA; Restrepo C; Parvizi J; Bernthal NM
J Arthroplasty; 2022 Dec; 37(12):2444-2448.e1. PubMed ID: 35843380
[TBL] [Abstract][Full Text] [Related]
25. Have Venous Thromboembolism Rates Decreased in Total Hip and Knee Arthroplasty?
Warren JA; Sundaram K; Anis HK; Kamath AF; Higuera CA; Piuzzi NS
J Arthroplasty; 2020 Jan; 35(1):259-264. PubMed ID: 31530463
[TBL] [Abstract][Full Text] [Related]
26. Multimodal prophylaxis in patients with a history of venous thromboembolism undergoing primary elective hip arthroplasty.
Gonzalez Della Valle A; Shanaghan KA; Nguyen J; Liu J; Memtsoudis S; Sharrock NE; Salvati EA
Bone Joint J; 2020 Jul; 102-B(7_Supple_B):71-77. PubMed ID: 32600195
[TBL] [Abstract][Full Text] [Related]
27. The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.
Chu JN; Maselli J; Auerbach AD; Fang MC
Thromb Res; 2017 Jul; 155():65-71. PubMed ID: 28501678
[TBL] [Abstract][Full Text] [Related]
28. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates.
Runner RP; Gottschalk MB; Staley CA; Pour AE; Roberson JR
J Arthroplasty; 2019 Apr; 34(4):729-734. PubMed ID: 30685257
[TBL] [Abstract][Full Text] [Related]
29. Aspirin Can Be Used as Prophylaxis for Prevention of Venous Thromboembolism After Revision Hip and Knee Arthroplasty.
Deirmengian GK; Heller S; Smith EB; Maltenfort M; Chen AF; Parvizi J
J Arthroplasty; 2016 Oct; 31(10):2237-40. PubMed ID: 27118182
[TBL] [Abstract][Full Text] [Related]
30. An Update on Venous Thromboembolism Rates and Prophylaxis in Hip and Knee Arthroplasty in 2020.
Santana DC; Emara AK; Orr MN; Klika AK; Higuera CA; Krebs VE; Molloy RM; Piuzzi NS
Medicina (Kaunas); 2020 Aug; 56(9):. PubMed ID: 32824931
[TBL] [Abstract][Full Text] [Related]
31. Anticoagulation in Revision Total Joint Arthroplasty: A Retrospective Review of 1917 Cases.
Manista GC; Batko BD; Sexton AC; Edmiston TA; Courtney PM; Hannon CP; Levine BR
Orthopedics; 2019 Nov; 42(6):323-329. PubMed ID: 31505013
[TBL] [Abstract][Full Text] [Related]
32. Thirty Days of Aspirin for Venous Thromboembolism Prophylaxis Is Adequate Following Total Knee Arthroplasty, Regardless of the Dose Used.
Shohat N; Ludwick L; Goel R; Ledesma J; Streicher S; Parvizi J
J Arthroplasty; 2021 Sep; 36(9):3300-3304. PubMed ID: 34052098
[TBL] [Abstract][Full Text] [Related]
33. Is Apixaban Safe and Effective for Venous Thromboembolism Prophylaxis After Primary Total Hip and Total Knee Arthroplasties?
Rooney T; Barrack RL; Clohisy JC; Nunley RM; Lawrie CM
J Arthroplasty; 2021 Jul; 36(7S):S328-S331. PubMed ID: 33888386
[TBL] [Abstract][Full Text] [Related]
34. Low-dose aspirin and the rate of symptomatic venous thromboembolic complications following primary shoulder arthroplasty.
Kirsch JM; Gutman M; Patel M; Rondon A; Ramsey ML; Abboud JA; Williams GR; Namdari S
J Shoulder Elbow Surg; 2021 Jul; 30(7):1613-1618. PubMed ID: 33536125
[TBL] [Abstract][Full Text] [Related]
35. Low-Dose Aspirin Administered for Venous Thromboembolism Prophylaxis Reduces the Incidence of Heterotopic Ossification in Total Joint Arthroplasty.
Van Nest DS; Clarkson S; Chisari E; Sherman MB; Parvizi J
J Arthroplasty; 2021 May; 36(5):1543-1547. PubMed ID: 33485696
[TBL] [Abstract][Full Text] [Related]
36. Prevention of postoperative venous thromboembolism in Japanese patients undergoing total hip or knee arthroplasty: two randomized, double-blind, placebo-controlled studies with three dosage regimens of enoxaparin.
Fuji T; Ochi T; Niwa S; Fujita S
J Orthop Sci; 2008 Sep; 13(5):442-51. PubMed ID: 18843459
[TBL] [Abstract][Full Text] [Related]
37. Tranexamic Acid Can Be Administered to Arthroplasty Patients Who Receive Aspirin for Venous Thromboembolic Prophylaxis.
Heller S; Secrist E; Shahi A; Chen AF; Parvizi J
J Arthroplasty; 2016 Jul; 31(7):1437-41. PubMed ID: 27026644
[TBL] [Abstract][Full Text] [Related]
38. Incidence of venous thromboembolism after total hip, total knee and hip fracture surgery at Waitemata District Health Board following a peer-reviewed audit.
Millar JS; Lawes CM; Farrington B; Andrew P; Misur P; Merriman E; Walker M
N Z Med J; 2020 Mar; 133(1511):52-60. PubMed ID: 32161421
[TBL] [Abstract][Full Text] [Related]
39. Incidence of Symptomatic Venous Thromboembolism (VTE) in 8,885 Elective Total Hip Arthroplasty Patients Receiving Post-operative Aspirin VTE Prophylaxis.
Coveney EI; Hutton C; Patel N; Whitehouse SL; Howell JR; Wilson MJ; Hubble MJ; Charity J; Kassam AM
Cureus; 2023 Mar; 15(3):e36464. PubMed ID: 37090282
[TBL] [Abstract][Full Text] [Related]
40. Time to Venous Thromboembolism Events Following Total Hip Arthroplasty: A Comparison Between Aspirin and Warfarin.
Shohat N; Goel R; Ludwick L; Parvizi J
J Arthroplasty; 2022 Jun; 37(6):1198-1202.e1. PubMed ID: 35149168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
